SCHEMBL22010269

SCHEMBL22010269

O=c1[nH]sc2cc(CN3CCC3)ccc12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 2/20 0.47
PARP1 P09874 10/20 0.43
KDM4E B2RXH2 2/20 0.41
HTT P42858 2/20 0.41
DDAH1 O94760 1/20 0.41
CASP3 P42574 1/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CXCR4 P61073 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92265 0.74 ALDH1A1 (0.56) ALDH1A1LMNAMAPTPOLBPARP1
SCHEMBL11737600 0.69 ALDH1A1 (0.61) ALDH1A1LMNAMAPTPOLBPARP1
SCHEMBL13963735 0.66 ALDH1A1 (0.45) ALDH1A1LMNAMAPTPOLBKDM4E
Ticlatone SCHEMBL193888 0.65 ALDH1A1 (0.61) ALDH1A1LMNAMAPTPOLBPARP1
Ticlatone SCHEMBL30165586 0.65 ALDH1A1 (0.61) ALDH1A1LMNAMAPTPOLBPARP1
SCHEMBL5807922 0.65 ALDH1A1 (0.61) ALDH1A1LMNAMAPTPOLBPARP1
SCHEMBL6406734 0.65 PARP1 (0.77) ALDH1A1PARP1KDM4EHPGDHSD17B10
Hydrochloric Acid SCHEMBL11779389 0.64 HRH3 (0.57) ALDH1A1POLBKDM4EHTTHRH3
SCHEMBL11201497 0.62 HRH3 (0.94) ALDH1A1POLBKDM4EHRH3SMN1; SMN2
SCHEMBL22010268 0.62 CHKA (0.40) ALDH1A1POLBPARP1HTTHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3880666-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-06-28 EP disclosed
WO-2020102100-A9 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-01-06 WO disclosed
WO-2020102100-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed